Leonid Poretsky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leonid Poretsky has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Dimiter Avtanski
Friedman Diabetes Institute, Lenox Hill Hospital, Northwell Health, New York, NY 10022, USA
6 shared publications Karina Ziskovich
5 shared publications- Radoslav Stojchevski
Friedman Diabetes Institute, Lenox Hill Hospital, Northwell Health, New York, NY 10022, USA
4 shared publications - Mitko Mladenov
Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, North Macedonia
3 shared publications - Nikola Hadzi-Petrushev
Institute of Biology, Faculty of Natural Sciences and Mathematics, Ss. Cyril and Methodius University, 1000 Skopje, North Macedonia
3 shared publications Rachel Goldman
3 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Elsevier in American Journal of Preventive Cardiology
Linking mental and cardiovascular health in gender diverse adults
- 23 September 2026
- Published by Elsevier in American Journal of Preventive Cardiology
Open AccessLinking mental and cardiovascular health in gender diverse adults
- Open Access
Expression of Genes Associated with Epithelial to Mesenchymal Transition in MCF-7 Breast Cancer Cells Treated with Monocarbonyl Analogs of Curcumin C66 and B2BrBC—RT-qPCR Array Dataset
Curcumin is a polyphenolic bio-compound derived from the rhizomes of the turmeric plant (Curcuma longa) that has proven anti-carcinogenic properties but poor bioavailability. By modifying its chemical structure, the monocarbonyl analogs of curcumin (MACs) possess improved stability, resorption, and circulation. This dataset presents RT-qPCR array analysis of 84 genes associated with Epithelial to Mesenchymal Transition (EMT), a key early event in cancer progression and metastasis, in human MCF-7 breast cancer cells. Cells were stimulated toward EMT reprogramming by treatment with a combination of EMT-inducing factors and co-treated with two experimental MACs, C66 or B2BrBC. Gene expression was measured using the human EMT QIAGEN RT2 Profiler kit, and results were obtained from three independent experiments. Gene expression changes are presented as both fold regulation and fold change values, with statistical significance determined by Student’s t-test (p < 0.05). This comprehensive dataset enables investigation into how MACs modulate the EMT transcriptome in breast cancer cells, with potential applications for understanding EMT mechanisms. The raw and processed data are publicly available and can be used for comparative analyses, validation studies, and bioinformatic analyses of EMT-related signaling pathways.
Open AccessExpression of Genes Associated with Epithelial to Mesenchymal Transition in MCF-7 Breast Cancer Cells Treated with Monocarbonyl Analogs of Curcumin C66 and B2BrBC—RT-qPCR Array Dataset
Curcumin is a polyphenolic bio-compound derived from the rhizomes of the turmeric plant (Curcuma longa) that has proven anti-carcinogenic properties but poor bioavailability. By modifying its chemical structure, the monocarbonyl analogs of curcumin (MACs) possess improved stability, resorption, and circulation. This dataset presents RT-qPCR array analysis of 84 genes associated with Epithelial to Mesenchymal Transition (EMT), a key early event in cancer progression and metastasis, in human MCF-7 breast cancer cells. Cells were stimulated toward EMT reprogramming by treatment with a combination of EMT-inducing factors and co-treated with two experimental MACs, C66 or B2BrBC. Gene expression was measured using the human EMT QIAGEN RT2 Profiler kit, and results were obtained from three independent experiments. Gene expression changes are presented as both fold regulation and fold change values, with statistical significance determined by Student’s t-test (p < 0.05). This comprehensive dataset enables investigation into how MACs modulate the EMT transcriptome in breast cancer cells, with potential applications for understanding EMT mechanisms. The raw and processed data are publicly available and can be used for comparative analyses, validation studies, and bioinformatic analyses of EMT-related signaling pathways.
- Open Access
- 21 January 2026
- Published by Springer Nature in Cancer Cell International
- Vol. 26  (1)
Assessment of the anticancer and antimetastatic effects of monocarbonyl analogs of curcumin, C66 and B2BrBC, in breast cancer cells
Background: Curcumin, a natural compound found in turmeric ( Curcuma longa ), demonstrates anticancer properties; however, it is characterized by poor bioavailability and stability. This study investigates the stability, antioxidant activity, and anticancer effects of two monocarbonyl analogs of curcumin (MACs), C66 and B2BrBC, in in vitro breast cancer models. Methods: Stability and antioxidant activity of C66 and B2BrBC were assessed using spectrophotometric assays. Their effects on breast cancer cells (MCF-7, BT-474, MDA-MB-231) were evaluated through MTT assay, wound-healing assay, and caspase-3 fluorescence microscopy. EMT modulation was examined via RT-qPCR, Western blot, and immunofluorescence analyses. A MILLIPLEX protein assay was used to analyze cancer metastasis-related protein expression. Results: C66 and B2BrBC demonstrated enhanced stability compared to curcumin. Both compounds significantly reduced breast cancer cell viability and migration, with B2BrBC showing higher potency. They effectively suppressed EMT, reversing EMT-inducer effects on epithelial and mesenchymal markers. C66 and B2BrBC modulated the expression of several metastasis-related proteins, including DKK1, OPG, and GDF15, in a cell line-dependent manner. Conclusions: C66 and B2BrBC exhibit improved stability and potent anticancer effects in breast cancer cells, effectively inhibiting cell viability, migration, and EMT. These compounds show promise as potential therapeutic agents for breast cancer, warranting further investigation in in vivo models.
- 21 January 2026
- Published by Springer Nature in Cancer Cell International
- Vol. 26  (1)
Open AccessAssessment of the anticancer and antimetastatic effects of monocarbonyl analogs of curcumin, C66 and B2BrBC, in breast cancer cells
Background: Curcumin, a natural compound found in turmeric ( Curcuma longa ), demonstrates anticancer properties; however, it is characterized by poor bioavailability and stability. This study investigates the stability, antioxidant activity, and anticancer effects of two monocarbonyl analogs of curcumin (MACs), C66 and B2BrBC, in in vitro breast cancer models. Methods: Stability and antioxidant activity of C66 and B2BrBC were assessed using spectrophotometric assays. Their effects on breast cancer cells (MCF-7, BT-474, MDA-MB-231) were evaluated through MTT assay, wound-healing assay, and caspase-3 fluorescence microscopy. EMT modulation was examined via RT-qPCR, Western blot, and immunofluorescence analyses. A MILLIPLEX protein assay was used to analyze cancer metastasis-related protein expression. Results: C66 and B2BrBC demonstrated enhanced stability compared to curcumin. Both compounds significantly reduced breast cancer cell viability and migration, with B2BrBC showing higher potency. They effectively suppressed EMT, reversing EMT-inducer effects on epithelial and mesenchymal markers. C66 and B2BrBC modulated the expression of several metastasis-related proteins, including DKK1, OPG, and GDF15, in a cell line-dependent manner. Conclusions: C66 and B2BrBC exhibit improved stability and potent anticancer effects in breast cancer cells, effectively inhibiting cell viability, migration, and EMT. These compounds show promise as potential therapeutic agents for breast cancer, warranting further investigation in in vivo models.
- Open Access
- 17 September 2024
- Published by Elsevier in Data in Brief
- Vol. 57, 110952
Impact of monocarbonyl analogs of curcumin (MACs) C66 and B2BrBC on the expression of diabetes-associated genes in streptozotocin-treated rat pancreatic RIN-m cells—Quantitative RT-PCR array data
- 17 September 2024
- Published by Elsevier in Data in Brief
- Vol. 57, 110952
Open AccessImpact of monocarbonyl analogs of curcumin (MACs) C66 and B2BrBC on the expression of diabetes-associated genes in streptozotocin-treated rat pancreatic RIN-m cells—Quantitative RT-PCR array data
- Open Access
- 21 April 2024
- Published by Elsevier in Journal of Clinical and Translational Endocrinology: Case Reports
- Vol. 32
Hyperglycemic DKA in a patient with type 2 diabetes mellitus on monotherapy with SGLT-2 inhibitor
- 21 April 2024
- Published by Elsevier in Journal of Clinical and Translational Endocrinology: Case Reports
- Vol. 32
Open AccessHyperglycemic DKA in a patient with type 2 diabetes mellitus on monotherapy with SGLT-2 inhibitor
- 27 September 2023
- Published by Springer Nature
- p. 1-13
Inflammation: Pathogenesis and Biological Markers
- 27 September 2023
- Published by Springer Nature
- p. 1-13
Inflammation: Pathogenesis and Biological Markers
- 24 August 2023
- Published by Elsevier in Endocrine Practice
- Vol. 29  (12) , 1017-1019
Recognizing the Impact of Ethnicity: Thyroid Neoplasia in Hispanic Americans
- 24 August 2023
- Published by Elsevier in Endocrine Practice
- Vol. 29  (12) , 1017-1019
Recognizing the Impact of Ethnicity: Thyroid Neoplasia in Hispanic Americans
- Open Access
- 13 January 2023
- Published by Elsevier in Metabolism Open
- Vol. 17, 100230
The effects of irisin and leptin on steroidogenic enzyme gene expression in human granulosa cells: In vitro studies
- 13 January 2023
- Published by Elsevier in Metabolism Open
- Vol. 17, 100230
Open AccessThe effects of irisin and leptin on steroidogenic enzyme gene expression in human granulosa cells: In vitro studies
- Open Access
- 3 March 2022
- Published by Elsevier in Metabolism Open
- Vol. 13, 100173
The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review
- 3 March 2022
- Published by Elsevier in Metabolism Open
- Vol. 13, 100173
Open AccessThe effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review